| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 24 Feb 25 | QTTB Q32 Bio | Stock Option Common Stock | Grant | Acquire A | No | No | 2.54 | 12,767 | 32.43 k | 12,767 |
| 24 Feb 25 | QTTB Q32 Bio | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 16.82 | 12,767 | 214.74 k | 0 |
| 8 Aug 24 | CGEM Cullinan Oncology | Stock Option Common Stock | Grant | Acquire A | No | No | 16.38 | 25,743 | 421.67 k | 25,743 |
| 13 Jun 24 | TRDA Entrada Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 16.45 | 16,000 | 263.20 k | 16,000 |
| 5 Jun 24 | VIGL Vigil Neuroscience | Stock Option Award Common Stock | Grant | Acquire A | No | No | 3.38 | 18,068 | 61.07 k | 18,068 |
